A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial

AIM: We tested the hypothesis that metformin may regress left ventricular hypertrophy (LVH) in patients who have coronary artery disease (CAD), with insulin resistance (IR) and/or pre-diabetes. METHODS AND RESULTS: We randomly assigned 68 patients (mean age 65 ± 8 years) without diabetes who have CA...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohan, Mohapradeep, Al-Talabany, Shaween, McKinnie, Angela, Mordi, Ify R, Singh, Jagdeep S S, Gandy, Stephen J, Baig, Fatima, Hussain, Muhammad S, Bhalraam, U, Khan, Faisel, Choy, Anna-Maria, Matthew, Shona, Houston, John Graeme, Struthers, Allan D, George, Jacob, Lang, Chim C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823615/
https://www.ncbi.nlm.nih.gov/pubmed/30993313
http://dx.doi.org/10.1093/eurheartj/ehz203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823615/
https://www.ncbi.nlm.nih.gov/pubmed/30993313
http://dx.doi.org/10.1093/eurheartj/ehz203

Ejemplares similares